Crescent Jumps Into VEGFxPD-1 Bispecific Race Via Merger With GlycoMimetics

 
• By Joseph Haas
Crescent will go public via a merger with troubled GlycoMimetics. (Shutterstock)

More from Deals

More from Therapy Areas